MTHFD1L is a novel prognostic marker and therapeutic target in cutaneous melanoma
Abstract Background Skin cutaneous melanoma (SKCM) is one of the highly malignant tumor. This study aimed to investigate the expression levels of MTHFD1L in cutaneous melanoma and to uncover its potential biological significance. Methods This investigation employed the TCGA-SKCM dataset along with c...
Saved in:
| Main Authors: | Xinlian Xie, Guangfu Shi, Kebin Ning, Zhenjie Wu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | Diagnostic Pathology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13000-025-01680-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
RUNX2 mediated epithelial mesenchymal transition induced by TGF beta and Smad signaling promotes malignant progression in glioma
by: Peng Zhou, et al.
Published: (2025-07-01) -
Role of the TGF-β/Smad3 pathway in pancreatic cancer cell growth and stem cell characteristics
by: Yanling Zhang, et al.
Published: (2025-08-01) -
Inhibitory effect of melatonin on peritoneal fibrosis in rats and its mechanism
by: ZHAO Hua, et al.
Published: (2017-01-01) -
Bioinformatics-based prognostic value and in vitro functional validation of PTK6 in cutaneous melanoma
by: Yanyan Niu, et al.
Published: (2025-07-01) -
Aging increases susceptibility to liver fibrosis through enhanced NAT10-mediated ac4C modification of TGFβ1 mRNA
by: Xuyun Peng, et al.
Published: (2025-08-01)